Factor
|
Group
|
Overall
|
---|
| |
N = 125
|
Age,y
| |
75 [66, 82]
|
Sex
|
M/F
|
85(68.0)/40 (32.0)
|
Cirrhosis
|
No/Yes
|
112 (89.6)/13(10.4)
|
Sepsis
|
Pulmonary
|
78 (62.4)
|
|
Nonpulmonary
|
47 (37.6)
|
APACHE.II
| |
23 [18, 27]
|
McCabe
|
1/2/3
|
114 (91.2)/5(4.0)/6(4.8)
|
ARDS severity
|
Mild
|
10 (8.0)
|
|
Moderate
|
58 (46.4)
|
|
Severe
|
57 (45.6)
|
SOFA
| |
7 [5, 11]
|
PaO2/FiO2, mmHg
| |
106.80 [75.1, 139.7]
|
CT.score
| |
213.3 [184.8, 268.5]
|
Albumin, g/dL
| |
2.8 [2.40, 3.20]
|
WBC
| |
9600 [4200, 14,400]
|
C-reactive protein, mg/dL
| |
15.94 [9.01, 25.70]
|
Lactate dehydrogenase, IU/L
| |
308 [246, 434]
|
DIC score
| |
3 [2, 4]
|
FDP, mg/L
| |
11.10 [1.50, 170.70]
|
Antithrombin III %
| |
66.00 [52.00, 80.00]
|
Platelet, X104
| |
17.90 [10.10, 26.40]
|
D.dimer.μg/ml.
| |
5.60 [2.70, 11.00]
|
AZM use (%)
| |
29(23.2)
|
Death (%)
| |
58 (46.4)
|
- n (%), median [IQR]
-
APACHE acute physiology and chronic health evaluation, ARDS acute respiratory distress syndrome, AZM azithromycin, DIC disseminated intravascular coagulation, FDP fibrin/fibrinogen degradation products, SOFA Sequential Organ Failure Assessment score, WBC white blood cell count